Bio Key International INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
BIO-key International reports a net loss of $7.16 million for 2025 amid ongoing liquidity challenges and Nasdaq delisting.
OQB
BIO-key International's 10-K filing reveals a strategic shift towards higher-margin license sales and cost reductions, despite a revenue decrease.
OQB
BIO-key International has filed an amendment to its annual report to correct a typographical error in the date of the auditor's report, with no other changes to the financial statements.
OQB
BIO-key International restated its 2023 quarterly financials due to revenue recognition errors and internal control weaknesses, while also reporting a 10% increase in annual revenue.